Marc B. Roitman

Representative Experience

• Prospect Medical Holdings. Represented the Transaction Committee of the Board in complex Chapter 11 cases involving regional healthcare operations across multiple states. Led an independent, fact-intensive investigation into related-party transactions and potential claims, enabling the Transaction Committee to approve global settlements that preserved estate value while maintaining uninterrupted patient care.
• Ascend Performance Materials. Represented the independent directors in multi-billion-dollar Chapter 11 cases. Conducted a comprehensive investigation into prepetition transactions and potential estate claims, guiding the directors to a global resolution that preserved litigation value for the company and its stakeholders.
• Rite Aid / Elixir. Counsel to the independent directors of Elixir, Rite Aid’s pharmacy benefit manager subsidiary, in connection with Rite Aid’s Chapter 11 cases. Advised on the value-maximizing sale of the Elixir business and led an independent investigation into intercompany transactions.
• Cyxtera Technologies. Represented the independent Restructuring Committee of the Board in complex chapter 11 cases, providing strategic guidance on a dual-track sale and recapitalization process that resulted in a value-maximizing asset sale, while conducting an independent investigation into pre-bankruptcy transactions that was essential to plan confirmation.
• GenesisCare. Advised the independent director in Chapter 11 cases complicated by worldwide operations, intense regulatory scrutiny in Australia, and the imperative of maintaining uninterrupted care for tens of thousands of patients. The investigation into the company’s historical relationship with its founder and former CEO produced recommendations that were integral to the Chapter 11 plan.
• GWG Holdings. Counsel to the independent directors of this financial services firm in Chapter 11 cases. Led an extensive investigation into complex dealings with a former subsidiary, which resulted in leadership changes at the CEO, CFO, and board level. Resolution of these issues was critical to obtaining confirmation of the company’s fully consensual plan of reorganization.
• Gulfport Energy Corporation. Counsel to the independent directors of one of the largest natural gas producers in the United States, investigating intercompany transactions scrutinized by multiple parties and helping to negotiate a global settlement incorporated into the Chapter 11 plan, which was supported by nearly all of the company’s creditors. The bankruptcy judge commented on the record that the independent directors’ role in the case was critically important, and that he “very much appreciate[d] [their] efforts, skills, talents and guidance.”
• Additional Katten Experience. Marc has advised companies, private equity sponsors, and independent directors on a broad range of out-of-court restructurings, liability management transactions, and distressed asset acquisitions and sales, including a number of significant matters that are not publicly disclosed.
• Prior Experience. Prior to joining Katten, Marc advised key parties in some of the most significant restructuring matters of that period, including Tribune Company, Gawker Media, PG&E, GenOn Energy, City of Detroit, and ResCap.